Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 25 04:00PM ET
11.95
Dollar change
+0.10
Percentage change
0.84
%
Index- P/E- EPS (ttm)-0.62 Insider Own41.49% Shs Outstand52.03M Perf Week-3.63%
Market Cap621.76M Forward P/E- EPS next Y-1.18 Insider Trans0.00% Shs Float30.44M Perf Month-10.35%
Income-32.32M PEG- EPS next Q-0.22 Inst Own56.31% Short Float3.85% Perf Quarter13.27%
Sales0.00M P/S- EPS this Y-18.63% Inst Trans-2.83% Short Ratio16.26 Perf Half Y126.33%
Book/sh4.03 P/B2.96 EPS next Y-46.03% ROA-13.84% Short Interest1.17M Perf Year-0.33%
Cash/sh3.03 P/C3.94 EPS next 5Y- ROE-14.31% 52W Range5.05 - 14.99 Perf YTD106.03%
Dividend Est.- P/FCF- EPS past 5Y-253.12% ROI-15.37% 52W High-20.28% Beta0.86
Dividend TTM- Quick Ratio22.06 Sales past 5Y0.00% Gross Margin- 52W Low136.63% ATR (14)0.85
Dividend Ex-Date- Current Ratio22.06 EPS Y/Y TTM-16.88% Oper. Margin0.00% RSI (14)46.22 Volatility6.15% 7.42%
Employees49 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price30.40
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q29.92% Payout- Rel Volume0.14 Prev Close11.85
Sales Surprise- EPS Surprise31.82% Sales Q/Q- EarningsMay 03 BMO Avg Volume72.16K Price11.95
SMA20-6.20% SMA50-2.01% SMA20031.88% Trades Volume10,551 Change0.84%
Date Action Analyst Rating Change Price Target Change
Aug-16-22Initiated H.C. Wainwright Buy $45
Jun-16-22Initiated ROTH Capital Buy $66
May-13-24 08:50AM
May-10-24 09:55AM
May-03-24 01:53PM
07:00AM
Mar-05-24 09:55AM
07:00AM Loading…
Feb-29-24 07:00AM
Jan-18-24 04:30PM
Jan-16-24 09:55AM
Dec-29-23 08:47AM
Dec-20-23 02:15PM
Dec-19-23 11:07AM
Nov-09-23 04:45PM
Sep-29-23 04:45PM
Aug-23-23 07:00AM
Jul-17-23 11:53AM
09:40AM Loading…
Jul-06-23 09:40AM
Jun-29-23 08:00AM
May-11-23 07:30AM
Mar-23-23 01:56PM
Mar-12-23 12:22PM
Mar-02-23 07:00AM
Feb-07-23 10:15AM
Jan-09-23 07:30AM
Nov-21-22 12:22PM
Nov-10-22 07:05AM
Sep-14-22 09:55AM
Aug-30-22 03:02PM
Aug-29-22 09:55AM
Aug-23-22 07:00AM
May-18-22 07:00AM
07:04AM Loading…
Mar-28-22 07:04AM
Mar-24-22 11:48AM
Dec-06-21 07:10AM
07:00AM
Oct-27-21 04:50AM
Sep-25-21 10:07AM
Sep-23-21 05:25PM
Jul-02-21 04:20PM
Jun-25-21 01:23PM
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schonharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.